Neisseria gonorrhoeae isolated from patients with disseminated infection are often of the porin (Por1A) serotype and resist killing by nonimmune normal human serum. The molecular basis of this resistance (termed stable serum resistance) in these strains has not been fully defined but is not related to sialylation of lipooligosaccharide. Here we demonstrate that Por1A bearing gonococcal strains bind more factor H, a critical downregulator of the alternative complement pathway, than their Por1B counterparts. This results in a sevenfold reduction in C3b, which is >75% converted to iC3b. Factor H binding to isogenic gonococcal strains that differed only in their porin serotype, confirmed that Por1A was the acceptor molecule for factor H. We identified a surface exposed region on the Por1A molecule that served as the binding site for factor H. We used gonococcal strains with hybrid Por1A/B molecules that differed in their surface exposed domains to localize the factor H binding site to loop 5 of Por1A. This was confirmed by inhibition of factor H binding using synthetic peptides corresponding to the putative exposed regions of the porin loops. The addition of Por1A loop 5 peptide in a serum bactericidal assay, which inhibited binding of factor H to the bacterial surface, permitted 50% killing of an otherwise completely serum resistant gonococcal strain. Collectively, these data provide a molecular basis to explain serum resistance of Por1A strains of N. gonorrhoeae.
Skip Nav Destination
Article navigation
17 August 1998
Article|
August 17 1998
Binding of Complement Factor H to Loop 5 of Porin Protein 1A: A Molecular Mechanism of Serum Resistance of Nonsialylated Neisseria gonorrhoeae
Sanjay Ram,
Sanjay Ram
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Search for other works by this author on:
Daniel P. McQuillen,
Daniel P. McQuillen
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Search for other works by this author on:
Sunita Gulati,
Sunita Gulati
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Search for other works by this author on:
Christopher Elkins,
Christopher Elkins
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Search for other works by this author on:
Michael K. Pangburn,
Michael K. Pangburn
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Search for other works by this author on:
Peter A. Rice
Peter A. Rice
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Search for other works by this author on:
Sanjay Ram
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Daniel P. McQuillen
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Sunita Gulati
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Christopher Elkins
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Michael K. Pangburn
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Peter A. Rice
From *The Maxwell Finland Laboratory for Infectious Diseases and the Evans Memorial Department of Clinical Research and Department of Medicine, Boston Medical Center, Boston, Massachusetts 02118; the ‡University of North Carolina, Chapel Hill, North Carolina 27599; and the §University of Texas Health Sciences Center, Tyler, Texas 75708
Address correspondence to Sanjay Ram, The Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center, Rm. 215, 774 Albany St., Boston, MA 02118. Phone: 617-534-5282; Fax: 617-534-5280; E-mail: [email protected]
Received:
March 13 1998
Revision Received:
June 02 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (4): 671–680.
Article history
Received:
March 13 1998
Revision Received:
June 02 1998
Citation
Sanjay Ram, Daniel P. McQuillen, Sunita Gulati, Christopher Elkins, Michael K. Pangburn, Peter A. Rice; Binding of Complement Factor H to Loop 5 of Porin Protein 1A: A Molecular Mechanism of Serum Resistance of Nonsialylated Neisseria gonorrhoeae . J Exp Med 17 August 1998; 188 (4): 671–680. doi: https://doi.org/10.1084/jem.188.4.671
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement